Related Experiment Video
Updated: Aug 16, 2026
10:51
Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Is C-26 hydroxylation an evolutionarily conserved steroid inactivation mechanism?
1Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden. steve.meaney@labmed.ki.se
Summary
Sterols are vital for eukaryotes, forming cell membranes and hormones. A conserved C-26 hydroxylation mechanism irreversibly inactivates plant and insect hormones, demonstrating evolutionary persistence.
Area of Science:
- Biochemistry
- Molecular Biology
- Evolutionary Biology
Background:
- Sterols are fundamental structural and hormonal precursors in higher eukaryotes.
- Sterol structures and primary roles (e.g., cholesterol in vertebrates, C28-C29 in plants/invertebrates) differ across species.
- Sterol conversion into hormones involves modifications like dealkylation, hydroxylation, and isomerization.
Purpose of the Study:
- To investigate the role of specific sterol modifications in hormone inactivation.
- To explore the evolutionary conservation of sterol deactivation mechanisms.
Main Methods:
- Analysis of sterol metabolism pathways.
- Biochemical assays to identify hydroxylation sites.
- Comparative genomics and evolutionary analysis.
Main Results:
- Irreversible inactivation of plant and insect hormones is mediated by C-26 hydroxylation.
- This C-26 hydroxylation represents an evolutionarily conserved mechanism.
- The mechanism persists despite diverse sterol requirements across species.
Conclusions:
- C-26 hydroxylation is a key conserved pathway for sterol-based hormone deactivation.
- This finding highlights an evolutionarily conserved strategy for regulating sterol-derived signaling molecules.
- The study underscores the ancient origins of specific metabolic pathways in eukaryotes.
Related Concept Videos
01:14Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:28Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
02:44Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide
Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.